Agnes Binagwaho1,2,3, Eric Remera1,4, Alice Uwase Bayingana5, Darius Gishoma6, Kirstin Woody Scott7, Madeline Goosman1, Eliza Campbell8, Mawuena Agbonyitor9, Yvonne Kayiteshonga4, Sabin Nsanzimana1,4. 1. University of Global Health Equity, Kigali, Rwanda. 2. Harvard Medical School, Boston, MA, USA. 3. Dartmouth College Geisel School of Medicine, Hanover, NH, USA. 4. Rwanda Biomedical Center, Kigali, Rwanda. 5. University of Global Health Equity, Kigali, Rwanda. abayingana@ughe.org. 6. University of Rwanda College of Medicine and Health Sciences, Kigali, Rwanda. 7. University of Michigan, Ann Arbor, Michigan, USA. 8. University of Virginia, Charlottesville, VA, USA. 9. Partners in Health, Freetown, Sierra Leone.
Abstract
BACKGROUND: Depression in children presents a significant health burden to society and often co-exists with chronic illnesses, such as human immunodeficiency virus (HIV). Research has demonstrated that 10-37% of children and adolescents living with HIV also suffer from depression. Low-and-middle income countries (LMICs) shoulder a disproportionate burden of HIV among other health challenges, but reliable estimates of co-morbid depression are lacking in these settings. Prior studies in Rwanda, a LMIC of 12 million people in East Africa, found that 25% of children living with HIV met criteria for depression. Though depression may negatively affect adherence to HIV treatment among children and adolescents, most LMICs fail to routinely screen children for mental health problems due to a shortage of trained health care providers. While some screening tools exist, they can be costly to implement in resource-constrained settings and are often lacking a contextual appropriateness. METHODS: Relying on international guidelines for diagnosing depression, Rwandan health experts developed a freely available, open-access Child Depression Screening Tool (CDST). To validate this tool in Rwanda, a sample of 296 children with a known diagnosis of HIV between ages 7-14 years were recruited as study participants. In addition to completing the CDST, all participants were evaluated by a mental health professional using a structured clinical interview. The validity of the CDST was assessed in terms of sensitivity, specificity, and a receiver operating characteristic (ROC) curve. RESULTS: This analysis found that depression continues to be a co-morbid condition among children living with HIV in Rwanda. For identifying these at-risk children, the CDST had a sensitivity of 88.1% and specificity of 96.5% in identifying risk for depression among children living with HIV at a cutoff score of 6 points. This corresponded with an area under the ROC curve of 92.3%. CONCLUSIONS: This study provides evidence that the CDST is a valid tool for screening depression among children affected by HIV in a resource-constrained setting. As an open-access and freely available tool in LMICs, the CDST can allow any health practitioner to identify children at risk of depression and refer them in a timely manner to more specialized mental health services. Future work can show if and how this tool has the potential to be useful in screening depression in children suffering from other chronic illnesses.
BACKGROUND:Depression in children presents a significant health burden to society and often co-exists with chronic illnesses, such as human immunodeficiency virus (HIV). Research has demonstrated that 10-37% of children and adolescents living with HIV also suffer from depression. Low-and-middle income countries (LMICs) shoulder a disproportionate burden of HIV among other health challenges, but reliable estimates of co-morbid depression are lacking in these settings. Prior studies in Rwanda, a LMIC of 12 million people in East Africa, found that 25% of children living with HIV met criteria for depression. Though depression may negatively affect adherence to HIV treatment among children and adolescents, most LMICs fail to routinely screen children for mental health problems due to a shortage of trained health care providers. While some screening tools exist, they can be costly to implement in resource-constrained settings and are often lacking a contextual appropriateness. METHODS: Relying on international guidelines for diagnosing depression, Rwandan health experts developed a freely available, open-access Child Depression Screening Tool (CDST). To validate this tool in Rwanda, a sample of 296 children with a known diagnosis of HIV between ages 7-14 years were recruited as study participants. In addition to completing the CDST, all participants were evaluated by a mental health professional using a structured clinical interview. The validity of the CDST was assessed in terms of sensitivity, specificity, and a receiver operating characteristic (ROC) curve. RESULTS: This analysis found that depression continues to be a co-morbid condition among children living with HIV in Rwanda. For identifying these at-risk children, the CDST had a sensitivity of 88.1% and specificity of 96.5% in identifying risk for depression among children living with HIV at a cutoff score of 6 points. This corresponded with an area under the ROC curve of 92.3%. CONCLUSIONS: This study provides evidence that the CDST is a valid tool for screening depression among children affected by HIV in a resource-constrained setting. As an open-access and freely available tool in LMICs, the CDST can allow any health practitioner to identify children at risk of depression and refer them in a timely manner to more specialized mental health services. Future work can show if and how this tool has the potential to be useful in screening depression in children suffering from other chronic illnesses.
Authors: Jane M Simoni; Steven A Safren; Lisa E Manhart; Karen Lyda; Cynthia I Grossman; Deepa Rao; Matthew J Mimiaga; Frank Y Wong; Sheryl L Catz; Michael B Blank; Ralph DiClemente; Ira B Wilson Journal: AIDS Behav Date: 2011-02
Authors: Denise M Gaughan; Michael D Hughes; James M Oleske; Kathleen Malee; Carol A Gore; Sharon Nachman Journal: Pediatrics Date: 2004-06 Impact factor: 7.124
Authors: Annika C Sweetland; Maria A Oquendo; Mohsin Sidat; Palmira F Santos; Sten H Vermund; Cristiane S Duarte; Melissa Arbuckle; Milton L Wainberg Journal: Ann Glob Health Date: 2014 Mar-Apr Impact factor: 2.462
Authors: Philip S Wang; Matthias Angermeyer; Guilherme Borges; Ronny Bruffaerts; Wai Tat Chiu; Giovanni DE Girolamo; John Fayyad; Oye Gureje; Josep Maria Haro; Yueqin Huang; Ronald C Kessler; Viviane Kovess; Daphna Levinson; Yoshibumi Nakane; Mark A Oakley Brown; Johan H Ormel; José Posada-Villa; Sergio Aguilar-Gaxiola; Jordi Alonso; Sing Lee; Steven Heeringa; Beth-Ellen Pennell; Somnath Chatterji; T Bedirhan Ustün Journal: World Psychiatry Date: 2007-10 Impact factor: 49.548